Trial intelligence / Profile preview

Sitagliptin vs Vildagliptin vs Metformin in Recently Diagnosed T2D

NCT04916093Phase 4Completed

Sponsor
Beni Suef University
Start
Dec 2019
Primary completion
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sitagliptin, vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Beni Suef University. Started Dec 2019; status: completed.

02

Drugs

sitagliptinvildagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT04916093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04916093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call